Sangal, Vartul and Harbottle, Heather and Mazzoni, Camila and Helmuth, Reiner and Guerra, Beatriz and Didelot, Xavier and Paglietti, Bianca and Rabsch, Wolfgang and Brisse, Sylvain and Weill, François-Xavier and Roumagnac, Philippe and Achtman, Mark (2010) Evolution and population structure of Salmonella enterica serovar Newport. Journal of Bacteriology, 192 (24). pp. 6465-6476. ISSN 1098-5530Full text not available in this repository. (Request a copy from the Strathclyde author)
Salmonellosis caused by Salmonella enterica serovar Newport is a major global public health concern, particularly because S. Newport isolates that are resistant to multiple drugs (MDR), including third-generation cephalosporins (MDR-AmpC phenotype), have been commonly isolated from food animals. We analyzed 384 S. Newport isolates from various sources by a multilocus sequence typing (MLST) scheme to study the evolution and population structure of the serovar. These were compared to the population structure of S. enterica serovars Enteritidis, Kentucky, Paratyphi B, and Typhimurium. Our S. Newport collection fell into three lineages, Newport-I, Newport-II, and Newport-III, each of which contained multiple sequence types (STs). Newport-I has only a few STs, unlike Newport-II or Newport-III, and has possibly emerged recently. Newport-I is more prevalent among humans in Europe than in North America, whereas Newport-II is preferentially associated with animals. Two STs of Newport-II encompassed all MDR-AmpC isolates, suggesting recent global spread after the acquisition of the blaCMY-2 gene. In contrast, most Newport-III isolates were from humans in North America and were pansusceptible to antibiotics. Newport was intermediate in population structure to the other serovars, which varied from a single monophyletic lineage in S. Enteritidis or S. Typhimurium to four discrete lineages within S. Paratyphi B. Both mutation and homologous recombination are responsible for diversification within each of these lineages, but the relative frequencies differed with the lineage. We conclude that serovars of S. enterica provide a variety of different population structures.
|Keywords:||population structure , salmonella enterica , Therapeutics. Pharmacology, Molecular Biology, Microbiology|
|Subjects:||Medicine > Therapeutics. Pharmacology|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences|
|Depositing user:||Pure Administrator|
|Date Deposited:||25 Jan 2012 11:20|
|Last modified:||22 Mar 2017 11:57|